Exact Sciences Stock Price To Book
| EXAS Stock | USD 56.03 1.14 2.08% |
EXACT Sciences fundamentals help investors to digest information that contributes to EXACT Sciences' financial success or failures. It also enables traders to predict the movement of EXACT Stock. The fundamental analysis module provides a way to measure EXACT Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EXACT Sciences stock.
Price To Book Ratio is likely to gain to 4.47 in 2025. EXACT | Price To Book |
EXACT Sciences Company Price To Book Analysis
EXACT Sciences' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current EXACT Sciences Price To Book | 3.19 X |
Most of EXACT Sciences' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EXACT Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
EXACT Price To Book Driver Correlations
Understanding the fundamental principles of building solid financial models for EXACT Sciences is extremely important. It helps to project a fair market value of EXACT Stock properly, considering its historical fundamentals such as Price To Book. Since EXACT Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of EXACT Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of EXACT Sciences' interrelated accounts and indicators.
Click cells to compare fundamentals
EXACT Price To Book Historical Pattern
Today, most investors in EXACT Sciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various EXACT Sciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to book growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of EXACT Sciences price to book as a starting point in their analysis.
EXACT Sciences Price To Book |
| Timeline |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
EXACT Book Value Per Share
Book Value Per Share |
|
Based on the latest financial disclosure, EXACT Sciences has a Price To Book of 3.1942 times. This is 87.56% lower than that of the Biotechnology sector and 57.97% lower than that of the Health Care industry. The price to book for all United States stocks is 66.41% higher than that of the company.
EXACT Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EXACT Sciences' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EXACT Sciences could also be used in its relative valuation, which is a method of valuing EXACT Sciences by comparing valuation metrics of similar companies.EXACT Sciences is currently under evaluation in price to book category among its peers.
EXACT Sciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, EXACT Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to EXACT Sciences' managers, analysts, and investors.Environmental | Governance | Social |
EXACT Fundamentals
| Return On Equity | -0.0676 | ||||
| Return On Asset | -0.0216 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 11.99 B | ||||
| Shares Outstanding | 185.08 M | ||||
| Shares Owned By Insiders | 1.02 % | ||||
| Shares Owned By Institutions | 98.98 % | ||||
| Number Of Shares Shorted | 10.29 M | ||||
| Price To Earning | (38.17) X | ||||
| Price To Book | 3.19 X | ||||
| Price To Sales | 3.77 X | ||||
| Revenue | 2.5 B | ||||
| Gross Profit | 1.96 B | ||||
| EBITDA | 41.88 M | ||||
| Net Income | (204.15 M) | ||||
| Cash And Equivalents | 728.04 M | ||||
| Cash Per Share | 4.11 X | ||||
| Total Debt | 2.55 B | ||||
| Debt To Equity | 0.77 % | ||||
| Current Ratio | 2.48 X | ||||
| Book Value Per Share | 17.35 X | ||||
| Cash Flow From Operations | 156.12 M | ||||
| Short Ratio | 5.31 X | ||||
| Earnings Per Share | (1.16) X | ||||
| Price To Earnings To Growth | (1.07) X | ||||
| Target Price | 72.19 | ||||
| Number Of Employees | 6.5 K | ||||
| Beta | 1.27 | ||||
| Market Capitalization | 10.16 B | ||||
| Total Asset | 6.47 B | ||||
| Retained Earnings | (3.47 B) | ||||
| Working Capital | 679.67 M | ||||
| Current Asset | 325.86 M | ||||
| Current Liabilities | 26.72 M | ||||
| Net Asset | 6.47 B |
About EXACT Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EXACT Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXACT Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXACT Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.